tiprankstipranks
Advertisement
Advertisement

IBRX Stock Latest News

Unusually active option classes on open June 29th
The FlyUnusually active option classes on open June 29th
22d ago
BE
WEN
Most of the Fastest Growing Companies Are Not in the S&P 500: How the Golden Eagle Dynamic Hypergrowth ETF is Built to Capture Them
PremiumMarket News
Most of the Fastest Growing Companies Are Not in the S&P 500: How the Golden Eagle Dynamic Hypergrowth ETF is Built to Capture Them
22d ago
BE
MU
ImmunityBio Shareholders Reelect Board at 2026 Annual Meeting
PremiumCompany Announcements
ImmunityBio Shareholders Reelect Board at 2026 Annual Meeting
1M ago
8K
IBRX
ImmunityBio Advances HPV-Positive Head and Neck Cancer Trial, Setting Up a New Catalyst for IBRX Investors
PremiumCompany Announcements
ImmunityBio Advances HPV-Positive Head and Neck Cancer Trial, Setting Up a New Catalyst for IBRX Investors
2M ago
IBRX
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
PremiumThe Fly
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
2M ago
BJ
EL
ImmunityBio highlights patient survey data on NMIBC at ISPOR 2026
PremiumThe FlyImmunityBio highlights patient survey data on NMIBC at ISPOR 2026
2M ago
IBRX
ImmunityBio presents health economic analysis on ANKTIVA plus BCG
Premium
The Fly
ImmunityBio presents health economic analysis on ANKTIVA plus BCG
2M ago
IBRX
Midday Fly By: Target, Lowe’s, TJX report Q1 beats
Premium
The Fly
Midday Fly By: Target, Lowe’s, TJX report Q1 beats
2M ago
BA
BZ
ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA
PremiumThe Fly
ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA
2M ago
IBRX
ImmunityBio announces results from ITC analyses of NAI with BCG
PremiumThe Fly
ImmunityBio announces results from ITC analyses of NAI with BCG
2M ago
IBRX
ImmunityBio Secures Exclusive Tokyo-172 BCG Rights in U.S.
PremiumCompany Announcements
ImmunityBio Secures Exclusive Tokyo-172 BCG Rights in U.S.
2M ago
8K
IBRX
ImmunityBio announces five U.S. patents issued for Anktiva with BCG
PremiumThe Fly
ImmunityBio announces five U.S. patents issued for Anktiva with BCG
2M ago
IBRX
ImmunityBio signs exclusive U.S. agreement with Japan BCG Laboratory
PremiumThe FlyImmunityBio signs exclusive U.S. agreement with Japan BCG Laboratory
2M ago
IBRX
ImmunityBio price target lowered to $12 from $13 at BTIG
Premium
The Fly
ImmunityBio price target lowered to $12 from $13 at BTIG
2M ago
IBRX
ImmunityBio reports Q1 EPS (62c) vs (15c) last year
Premium
The Fly
ImmunityBio reports Q1 EPS (62c) vs (15c) last year
3M ago
IBRX
ImmunityBio presents new comparison results on Anktiva, TAR-200
PremiumThe Fly
ImmunityBio presents new comparison results on Anktiva, TAR-200
3M ago
IBRX
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
PremiumCompany Announcements
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
3M ago
IBRX
ImmunityBio announces availability of ANKTIVA in Saudi Arabia
PremiumThe Fly
ImmunityBio announces availability of ANKTIVA in Saudi Arabia
3M ago
IBRX
ImmunityBio call volume above normal and directionally bullish
PremiumThe Fly
ImmunityBio call volume above normal and directionally bullish
3M ago
IBRX
ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
PremiumClass ActionImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
3M ago
IBRX
ImmunityBio reports preliminary Q1 net product revenue $44.2M
Premium
The Fly
ImmunityBio reports preliminary Q1 net product revenue $44.2M
3M ago
IBRX
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
Premium
Company Announcements
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
4M ago
8K
IBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >